Study of a new weight-loss medicine in Chinese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be a Chinese adult (born in China, living in mainland China, with both parents of Chinese descent).
- Your body mass index (BMI) must be between 24 and 45, and you must weigh more than 110 pounds (50 kg).
- You must be otherwise healthy, with no serious medical conditions (such as heart, liver, kidney, or mental health problems).
- You must not have a personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or MEN2 syndrome.
- You must not be pregnant, breastfeeding, or planning pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests a once-weekly medicine called PF-08653944 to see if it helps Chinese adults lose weight compared to a placebo (a pill with no active medicine). It may be an option if you have been unable to lose weight through diet alone.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.